Several clinical studies have addressed the role of the HGF/MET pathway in diverse types of cancer, such as gastric [6], colorectal [7], breast [8], hepatocellular [9], pancreatic [10], lung [11] and renal cancer [12]. This evidence concerns the gene MET and cancer.